Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AN2 Therapeutics (ANTX)

AN2 Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ANTX
DateTimeSourceHeadlineSymbolCompany
14/02/202521:30Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ANTXAN2 Therapeutics Inc
13/02/202521:30Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ANTXAN2 Therapeutics Inc
29/01/202521:00Business WireAN2 Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceNASDAQ:ANTXAN2 Therapeutics Inc
08/01/202501:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANTXAN2 Therapeutics Inc
08/01/202500:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANTXAN2 Therapeutics Inc
08/01/202500:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANTXAN2 Therapeutics Inc
23/12/202423:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANTXAN2 Therapeutics Inc
23/12/202423:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANTXAN2 Therapeutics Inc
23/12/202423:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANTXAN2 Therapeutics Inc
23/12/202423:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANTXAN2 Therapeutics Inc
11/12/202401:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANTXAN2 Therapeutics Inc
28/11/202400:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANTXAN2 Therapeutics Inc
21/11/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANTXAN2 Therapeutics Inc
19/11/202401:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANTXAN2 Therapeutics Inc
14/11/202412:00Business WireAN2 Therapeutics to Participate at Upcoming Investor ConferencesNASDAQ:ANTXAN2 Therapeutics Inc
13/11/202421:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANTXAN2 Therapeutics Inc
13/11/202421:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANTXAN2 Therapeutics Inc
13/11/202421:00Business WireAN2 Therapeutics Reports Third Quarter 2024 Financial Results, Provides Important EBO-301 Update and Highlights Progress Across Boron Chemistry PipelineNASDAQ:ANTXAN2 Therapeutics Inc
05/11/202421:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANTXAN2 Therapeutics Inc
05/11/202421:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANTXAN2 Therapeutics Inc
05/11/202421:49Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ANTXAN2 Therapeutics Inc
05/11/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANTXAN2 Therapeutics Inc
17/10/202411:00Business WireAN2 Therapeutics Receives Continuation Grant to Discover Novel Boron Based Therapies for Tuberculosis (caused by Mycobacterium tuberculosis) and MalariaNASDAQ:ANTXAN2 Therapeutics Inc
28/08/202420:00Business WireAN2 Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ANTXAN2 Therapeutics Inc
19/08/202410:07Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]NASDAQ:ANTXAN2 Therapeutics Inc
19/08/202410:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANTXAN2 Therapeutics Inc
16/08/202411:00Business WireAN2 Therapeutics Adopts Limited Duration Stockholder Rights PlanNASDAQ:ANTXAN2 Therapeutics Inc
13/08/202420:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANTXAN2 Therapeutics Inc
13/08/202420:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANTXAN2 Therapeutics Inc
13/08/202420:01Business WireAN2 Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business and Scientific HighlightsNASDAQ:ANTXAN2 Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ANTX